Working… Menu
Trial record 1 of 1 for:    Recruiting, Not yet recruiting Studies | mavacamten septal
Previous Study | Return to List | Next Study

A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy (VALOR-HCM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04349072
Recruitment Status : Recruiting
First Posted : April 16, 2020
Last Update Posted : June 7, 2021
Information provided by (Responsible Party):
MyoKardia, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2024
Estimated Study Completion Date : December 2024